FSK-Rosseti PAO
MOEX:FEES
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FSK-Rosseti PAO
MOEX:FEES
|
RU |
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
Beter Bed Holding NV
AEX:BBED
|
NL |
|
C
|
Cresud SACIF y A
F:CD8
|
AR |
|
T
|
Thumbage Co Ltd
KOSDAQ:208640
|
KR |
|
Asiamet Resources Ltd
LSE:ARS
|
CA |
|
S
|
SEI Medical PCL
SET:SEI
|
TH |
|
Krispy Kreme Inc
NASDAQ:DNUT
|
US |
|
G
|
Groupe Tera SA
PAR:ALGTR
|
FR |
|
M
|
Moda InnoChips Co Ltd
KOSDAQ:080420
|
KR |
|
S
|
Sammok S-Form Co Ltd
KOSDAQ:018310
|
KR |
|
Sparebanken Norge
F:K7I
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FEES's stock price target?
Not Available
FEES doesn't have any price targets made by Wall Street professionals.
What is FSK-Rosseti PAO's Revenue forecast?
Projected CAGR
-44%
For the last 13 years the
compound annual growth rate for
FSK-Rosseti PAO's revenue is
20%.
The projected
CAGR
for the next 3 years is
-44%.
What is FSK-Rosseti PAO's Operating Income forecast?
Projected CAGR
-25%
For the last 13 years the
compound annual growth rate for
FSK-Rosseti PAO's operating income is
15%.
The projected
CAGR
for the next 4 years is
-25%.